financetom
Business
financetom
/
Business
/
China's internet regulator warns Kuaishou, Weibo over content violations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China's internet regulator warns Kuaishou, Weibo over content violations
Sep 21, 2025 4:15 AM

BEIJING, Sept 20 (Reuters) - China's top internet

regulator issued warnings and imposed disciplinary measures

against live-streaming platform Kuaishou ( KUASF ) and social

media platform Weibo ( WB ) on Saturday, citing failures in

content management.

The Cyberspace Administration of China said in two separate

statements the actions to be taken include summoning company

representatives, issuing official warnings and ordering

rectifications within a specified time frame.

According to the CAC, both platforms failed to fulfill their

core responsibility of content management, citing the frequent

appearance of problematic entries on their main trending lists,

particularly those hyping celebrity gossip and trivial personal

updates.

In a statement, Weibo ( WB ) said it "takes the matter very

seriously" and "sincerely accepts the criticism and disciplinary

decisions" from the authorities.

"A special task force was immediately established to carry

out rectification work, aiming to address governance issues

around the trending list with the highest standards and

strictest requirements, and to fully assume responsibility for

content management," the company said.

Kuaishou ( KUASF ) did not immediately respond to a request for

comment.

The CAC's announcement came a day after China's market

watchdog launched an investigation into Kuaishou's ( KUASF ) e-commerce

unit Kuaigou for suspected violations of the nation's e-commerce

law.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sarepta Therapeutics' Gets Label Expansion for Elevidys in 'Best-case Scenario,' BofA Securities Says
Sarepta Therapeutics' Gets Label Expansion for Elevidys in 'Best-case Scenario,' BofA Securities Says
Jun 21, 2024
11:38 AM EDT, 06/21/2024 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) received label expansion from the US Food and Drug Administration for Elevidys to treat ambulatory Duchenne muscular dystrophy, marking a best-case scenario and exceeding expectations, BofA Securities said Thursday in a report. Sarepta said late Thursday the agency approved the label expansion to include patients ages 4 and...
Toyota Texas to Expand With $531 Million Investment
Toyota Texas to Expand With $531 Million Investment
Jun 21, 2024
11:34 AM EDT, 06/21/2024 (MT Newswires) -- Toyota Motor ( TM ) said Friday that Toyota Texas is expanding in the state with a new $531 million investment that will bring more than 400 new jobs to San Antonio. The investment will also bring a new onsite 500,000-square-foot facility that will be dedicated to the production of drivetrain parts, Toyota...
Nike's Product Launches Could Drive Sales Turnaround, BofA Says
Nike's Product Launches Could Drive Sales Turnaround, BofA Says
Jun 21, 2024
11:35 AM EDT, 06/21/2024 (MT Newswires) -- Nike's ( NKE ) commitment to faster and more meaningful product launches could drive sales turnaround in the second half of fiscal 2025, BofA Securities said in a note to clients. We have seen green shoots on the innovation front as three of its major retailers...are energized by its new products, BofA said,...
Why Gilead Sciences Stock Is Trading Higher Friday
Why Gilead Sciences Stock Is Trading Higher Friday
Jun 21, 2024
Gilead Sciences, Inc. ( GILD ) stock is moving higher Friday on continued strength following the company’s Phase 3 HIV data. What To Know: On Thursday before the market opened, Gilead announced efficacy data for its possible HIV prevention drug, Lenacapavir. The twice-yearly injectable indicated a 100% efficacy for HIV prevention in cisgender women. This data comes from the company’s...
Copyright 2023-2026 - www.financetom.com All Rights Reserved